NCT05774951 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy Status RECRUITING Phase PHASE3
NCT05768139 First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05766410 A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC Status RECRUITING Phase PHASE2
NCT05638594 Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer Status RECRUITING Phase PHASE2
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy Status RECRUITING Phase PHASE2
NCT05569811 NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05514054 A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05487092 Letrozole in Preventing Recurrence of Endometrioma Following Laparoscopic Ovarian Cystectomy Status RECRUITING Phase NA
NCT05467891 Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT05464810 Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer Status RECRUITING Phase EARLY_PHASE1
NCT05341817 The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy Status RECRUITING Phase PHASE4
NCT05304273 Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages Status COMPLETED Phase PHASE3
NCT05226871 Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05206448 Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05183828 Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer Status RECRUITING Phase PHASE4
NCT05161195 Roll-over Study to Allow Continued Access to Ribociclib Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05106712 Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women Status UNKNOWN Phase NA
NCT05075863 Efficacy of Letrozole Versus Clomiphene Citrate on Ovulation Induction in Patients With Polycystic Ovarian Syndrome Status COMPLETED Phase NA